Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Haemophilus influenzae type b Polyribosylribitol Phosphate Capsule (PRP Capsule)
- Target
- PRP Capsule
- Molecular classification
- Polysaccharide, Capsular polysaccharide
01
Overview
The polyribosylribitol phosphate (PRP) capsule is a polysaccharide structure that forms the outermost layer of Haemophilus influenzae type b (Hib). This capsule is the primary virulence factor of Hib, enabling it to evade host immune responses and cause invasive diseases. It is a linear polymer composed of repeating units of ribose and ribitol-5-phosphate. Antibody responses directed against PRP are critical for effective opsonization and clearance. Hib vaccines use purified or conjugated forms of the PRP polysaccharide to stimulate an immune response.
- Other names
- Hib PRP CapsulePolyribosylribitol PhosphatePRPHaemophilus influenzae type b capsule
02
Mechanism of action
Vaccine-induced antibody production against PRP, leading to opsonization, complement activation, and phagocytosis of Hib bacteria.
03
Biological functions
Immune evasionProtection against phagocytosisComplement inhibitionAntigen
04
Disease associations
InfectionMeningitisSepsisEpiglottitisPneumoniaSeptic arthritis
05
Safety considerations
Vaccine-related side effects (generally mild)Vaccine failure (rare, but possible in immunocompromised individuals)
06
Interacting drugs
Hib conjugate vaccines
07
Biomarkers
Anti-PRP antibody levels (correlate with protection)
Beyond the preview
Go deeper on Haemophilus influenzae type b Polyribosylribitol Phosphate Capsule (PRP Capsule).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Haemophilus influenzae type b Polyribosylribitol Phosphate Capsule (PRP Capsule).